Mesoridazine besylate - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for mesoridazine besylate and what is the scope of freedom to operate?
Mesoridazine besylate
is the generic ingredient in one branded drug marketed by Novartis and is included in three NDAs. Additional information is available in the individual branded drug profile pages.There are two drug master file entries for mesoridazine besylate.
Summary for mesoridazine besylate
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 3 |
Drug Master File Entries: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 52 |
Patent Applications: | 2,577 |
DailyMed Link: | mesoridazine besylate at DailyMed |
Medical Subject Heading (MeSH) Categories for mesoridazine besylate
Anatomical Therapeutic Chemical (ATC) Classes for mesoridazine besylate
US Patents and Regulatory Information for mesoridazine besylate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis | SERENTIL | mesoridazine besylate | TABLET;ORAL | 016774-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Novartis | SERENTIL | mesoridazine besylate | INJECTABLE;INJECTION | 016775-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Novartis | SERENTIL | mesoridazine besylate | TABLET;ORAL | 016774-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |